{
    "title": "Biogen to pay Forward Pharma $1.25 bln to protect MS drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4128290/Biogen-pay-1-25-bln-license-fees-protect-MS-drug.html",
    "date": "2017-01-17",
    "keywords": [
        "tecfidera",
        "biogen",
        "patent",
        "royalty",
        "pharma",
        "percent",
        "agreement",
        "gmt",
        "companys",
        "deal",
        "property",
        "cash",
        "market",
        "bln",
        "drug",
        "email",
        "jan",
        "inc",
        "tuesday",
        "sclerosis",
        "insurance",
        "policy",
        "treatment",
        "diseasebiogen",
        "dispute",
        "dimethyl",
        "ingredient",
        "share",
        "portion",
        "windfall",
        "stock",
        "distributionsthe",
        "biotech",
        "hook",
        "company",
        "future",
        "forward",
        "end",
        "executive",
        "michel",
        "vounatsos",
        "statementthirdquarter",
        "revenue",
        "period",
        "leader",
        "ms",
        "uncertainty",
        "term",
        "cliff",
        "growth",
        "capital",
        "analyst",
        "bill",
        "berkrot",
        "york",
        "grover",
        "ankur",
        "banerjee",
        "bengaluru",
        "editing",
        "kerr",
        "brown"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}